Glucocorticoids in innate immunity: More transactivation than transrepression!

Blood

Volumn 109, Issue 3, 2007, Pages 852-853

  Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; DNA MICROARRAY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE TARGETING; HUMAN; INNATE IMMUNITY; MONOCYTE; NOTE; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION; TRANSGENE;

EID: 33846867493     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-11-056853     Document Type: Note

References (6)

1. Hench PS, Kendall EC, Slocumb CH, et al. The effect of the adrenal cortex (17-hydroxy-11-dehydrocortisone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis: preliminary report. Proc Staff Meet Mayo Clin. 1949;24:181-197.
2. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids: new mechanisms for old drugs. N Engl J Med. 2005;353:1711-1723.
3. Cronstein BN, Montesinos MC, Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A. 1999;96:6377-6381.
4. Moraes LA, Paul-Clark MJ, Rickman A, et al. Ligand-specific glucocorticoid receptor activation in human platelets. Blood. 2005;106:4167-4175.
5. Lowenberg M, Tuynman J, Bilderbeek J, et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood. 2005;106:1703-1710.
6. Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell. 2000;5:831-840.